z-logo
open-access-imgOpen Access
Performance of existing risk scores around heart transplantation: validation study in a 4‐year cohort
Author(s) -
Nguyen Lee S.,
Coutance Guillaume,
Ouldamar Salima,
Zahr Noel,
Brechot Nicolas,
Galeone Antonella,
Bougle Adrien,
Lebreton Guillaume,
Leprince Pascal,
Varnous Shaida
Publication year - 2018
Publication title -
transplant international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.998
H-Index - 82
eISSN - 1432-2277
pISSN - 0934-0874
DOI - 10.1111/tri.13122
Subject(s) - medicine , heart transplantation , heart failure , receiver operating characteristic , cohort , ventricular assist device , transplantation , framingham risk score , cohort study , cardiology , disease
Summary Several risk scores exist to help identify best candidate recipients for heart transplantation ( HT x). This study describes the performance of five heart failure risk scores and two post‐ HT x mortality risk scores in a French single‐centre cohort. All patients listed for HT x through a 4‐year period were included. Waiting‐list risk scores [Heart Failure Survival Score ( HFSS ), Seattle Heart Failure Model ( SHFM ), Meta‐Analysis Global Group in Chronic Heart Failure ( MAGGIC ), Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure ( OPTIMIZE ‐ HF ) and Get With The Guidelines‐Heart Failure ( GWTG ‐ HF )] and post‐ HT x scores Index for Mortality Prediction After Cardiac Transplantation ( IMPACT and CARRS ) were computed. Main outcomes were 1‐year mortality on waiting list and after HT x. Performance was assessed using receiver operator characteristic ( ROC ), calibration and goodness‐of‐fit analyses. The cohort included 414 patients. Waiting‐list mortality was 14.0%, and post‐ HT x mortality was 16.3% at 1‐year follow‐up. Heart failure risk scores had adequate discrimination regarding waiting‐list mortality ( ROC AUC for HFSS  = 0.68, SHFM  = 0.74, OPTIMIZE ‐ HF  = 0.72, MAGGIC  = 0.70 and GWTG  = 0.77; all P ‐values <0.05). On the contrary, post‐ HT x risk scores did not discriminate post‐ HT x mortality ( AUC for IMPACT  = 0.58, and CARRS  = 0.48, both P ‐values >0.50). Subgroup analysis on patients undergoing HT x after ventricular assistance device ( VAD ) implantation (i.e. bridge‐to‐transplantation) ( n  = 36) showed an IMPACT AUC  = 0.72 ( P  < 0.001). In this single‐centre cohort, existing heart failure risk scores were adequate to predict waiting‐list mortality. Post‐ HT x mortality risk scores were not, except in the VAD subgroup.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here